PACS Group (NYSE:PACS - Get Free Report) is anticipated to issue its Q1 2026 resultson Thursday, May 7th. Analysts expect the company to announce earnings of $0.4118 per share and revenue of $1.3630 billion for the quarter. Parties may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Wednesday, May 20, 2026 at 4:00 PM ET.
PACS Group Stock Up 0.7%
PACS stock opened at $33.37 on Thursday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.36. PACS Group has a fifty-two week low of $7.50 and a fifty-two week high of $43.08. The firm's 50-day simple moving average is $34.85 and its 200 day simple moving average is $31.03. The stock has a market cap of $5.24 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 1.08 and a beta of 0.06.
Insider Activity at PACS Group
In related news, COO Joshua Jergensen sold 36,335 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $34.28, for a total transaction of $1,245,563.80. Following the transaction, the chief operating officer owned 2,667,347 shares in the company, valued at $91,436,655.16. This trade represents a 1.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 70.40% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in PACS. Alyeska Investment Group L.P. boosted its position in shares of PACS Group by 159.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company's stock valued at $86,378,000 after purchasing an additional 1,382,984 shares in the last quarter. Marshall Wace LLP boosted its position in shares of PACS Group by 348.6% during the 3rd quarter. Marshall Wace LLP now owns 1,010,906 shares of the company's stock valued at $13,880,000 after purchasing an additional 785,537 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of PACS Group by 120.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,129,612 shares of the company's stock valued at $14,595,000 after purchasing an additional 617,124 shares in the last quarter. Balyasny Asset Management L.P. boosted its position in shares of PACS Group by 67.3% during the 3rd quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company's stock valued at $18,621,000 after purchasing an additional 545,348 shares in the last quarter. Finally, Nuveen LLC boosted its position in shares of PACS Group by 284.7% during the 4th quarter. Nuveen LLC now owns 579,239 shares of the company's stock valued at $22,237,000 after purchasing an additional 428,672 shares in the last quarter.
Analyst Ratings Changes
PACS has been the topic of a number of analyst reports. Royal Bank Of Canada increased their price objective on shares of PACS Group from $47.00 to $52.00 and gave the stock an "outperform" rating in a report on Friday, February 27th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of PACS Group in a report on Friday, March 27th. Zacks Research raised shares of PACS Group from a "hold" rating to a "strong-buy" rating in a report on Wednesday, March 4th. Wall Street Zen raised shares of PACS Group from a "hold" rating to a "buy" rating in a report on Sunday, February 15th. Finally, Oppenheimer increased their price objective on shares of PACS Group from $40.00 to $42.00 and gave the stock an "outperform" rating in a report on Wednesday, March 4th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $44.40.
Get Our Latest Stock Analysis on PACS
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.